In mice, MT-II was shown to improve peripheral insulin sensitivity independent of diet while also increasing Glut4 mRNA expression in skeletal muscle [14]
If pharmacy transparency is important to you, and it probably should be, this is a factor worth weighing heavily in your decision
The push for regulatory change is being amplified by attorneys involved in the New Jersey multicounty litigation effort, who argue that Novo Nordisk has long been aware of this potential risk but has failed to update its labeling accordingly
Cleveland Clinic Journal of Medicine 2012
In fact, there have been several studies showing that long-term use of GLP-1 RAs may have benefits for blood sugar control, kidney function, blood pressure, and heart disease risk
Clinical trial results show the average across large groups of people, which means some lost more while others lost less